These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17504869)

  • 1. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
    Karantanis D; Bogsrud TV; Wiseman GA; Mullan BP; Subramaniam RM; Nathan MA; Peller PJ; Bahn RS; Lowe VJ
    J Nucl Med; 2007 Jun; 48(6):896-901. PubMed ID: 17504869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
    Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
    Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction.
    Kim SS; Kim SJ; Bae YT; Lee JY; Kim BH; Kim YK; Kim IJ
    Thyroid; 2012 Jan; 22(1):53-8. PubMed ID: 22142373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary 18F-FDG Uptake Correlates With Serum TSH Levels in Subjects With Diffuse Thyroid 18F-FDG Uptake.
    Jeong YH; Kim D; Lee JW; Rhee Y; Nam KH; Yun M; Kim CK
    Clin Nucl Med; 2015 Aug; 40(8):632-6. PubMed ID: 26018720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET/CT images.
    Han YM; Kim YC; Park EK; Choe JG
    AJR Am J Roentgenol; 2010 Jul; 195(1):223-8. PubMed ID: 20566820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of thyroid uptake on F18-fluorodeoxyglucose positron emission tomography.
    Liu Y
    Ann Nucl Med; 2009 Jan; 23(1):17-23. PubMed ID: 19205834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid stimulating hormone levels.
    Pruthi A; Choudhury PS; Gupta M; Taywade S
    Indian J Nucl Med; 2015; 30(1):16-20. PubMed ID: 25589800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism.
    Rothman IN; Middleton L; Stack BC; Bartel T; Riggs AT; Bodenner DL
    Eur Arch Otorhinolaryngol; 2011 Oct; 268(10):1501-4. PubMed ID: 21327732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic thyroiditis: diffuse uptake of FDG at PET.
    Yasuda S; Shohtsu A; Ide M; Takagi S; Takahashi W; Suzuki Y; Horiuchi M
    Radiology; 1998 Jun; 207(3):775-8. PubMed ID: 9609903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of patterns of incidental thyroid uptake at (18)F-FDG PET/CT.
    Agrawal K; Weaver J; Ngu R; Krishnamurthy Mohan H
    Clin Radiol; 2015 May; 70(5):536-43. PubMed ID: 25687827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse thyroid uptake incidentally found on 18F-fluorodeoxyglucose positron emission tomography in subjects without cancer history.
    Lee JY; Choi JY; Choi YH; Hyun SH; Moon SH; Jang SJ; Choe YS; Lee KH; Kim BT
    Korean J Radiol; 2013; 14(3):501-9. PubMed ID: 23690721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huge thyroid uptake of 18F-FDG in a patient with Hashimoto's thyroiditis referred for a malignant thyroid lesion.
    Yoshihara A; Isozaki O; Okubo Y; Maki M; Kusakabe K; Takano K
    Thyroid; 2008 May; 18(5):579-80. PubMed ID: 18407754
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical significance of patterns of increased [
    Tsubaki F; Kurata S; Tani J; Sumi A; Fujimoto K; Abe T
    Jpn J Radiol; 2018 Mar; 36(3):181-193. PubMed ID: 29280068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of FDG uptake in bilateral thyroid glands.
    Chen YK; Chen YL; Cheng RH; Yeh CL; Lee CC; Hsu CH
    Nucl Med Commun; 2007 Feb; 28(2):117-22. PubMed ID: 17198352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine.
    Schmidt M; Voell M; Rahlff I; Dietlein M; Kobe C; Faust M; Schicha H
    Thyroid; 2008 Jul; 18(7):755-60. PubMed ID: 18631004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary 18F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on 18F-FDG PET/CT.
    Ding Y; Wu S; Xu J; Wang H; Ma C
    Nucl Med Commun; 2019 Jan; 40(1):57-62. PubMed ID: 30422898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between anti-thyroid peroxidase antibody levels and diffuse thyroid uptake of
    Edo N; Morita K; Sakamoto M; Kaminaga T; Edo H; Okamura E; Ogawa M; Tsukamoto K; Okinaga H; Ishikawa T
    Thyroid Res; 2018; 11():14. PubMed ID: 30349584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.
    Gubbi S; Al-Jundi M; Del Rivero J; Jha A; Knue M; Zou J; Turkbey B; Carrasquillo JA; Lin E; Pacak K; Klubo-Gwiezdzinska J; Lin FI
    Front Endocrinol (Lausanne); 2020; 11():587065. PubMed ID: 33551992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.